Skinjay develops and markets in-shower micro-nebulization devices that deliver essential oils to the skin and into the lungs. Its product combines a mixer and essential oil capsules that vaporize alongside warm water to create a relaxing shower experience. The company positions the vaporized oils as complementary to skin and respiratory tract microbiomes. Skinjay raised €3.5m and intends to use the funds to accelerate international expansion and bolster R&D, particularly in respiratory microbiome research. The financing was provided by Seventure Partners via its Health for Life Capital investment vehicle. Founded by Nicolas Pasquier in 2012, the company is based in Paris, France.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Jan 2017